China’s Cathay Biotech Inc, a producer of chemical intermediates, is seeking to raise 5.6 billion yuan ($799 million) in an initial public offering (IPO) on Shanghai’s Nasdaq-style STAR Market, according to a company filing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
